A detailed history of Two Sigma Investments, LP transactions in Ac Immune Sa stock. As of the latest transaction made, Two Sigma Investments, LP holds 57,321 shares of ACIU stock, worth $187,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,321
Previous 99,343 42.3%
Holding current value
$187,439
Previous $396,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.99 - $4.2 $125,645 - $176,492
-42,022 Reduced 42.3%
57,321 $216,000
Q2 2024

Aug 14, 2024

BUY
$2.29 - $4.87 $227,495 - $483,800
99,343 New
99,343 $396,000
Q2 2023

Aug 14, 2023

BUY
$1.85 - $3.4 $28,266 - $51,948
15,279 New
15,279 $45,000
Q4 2021

Feb 14, 2022

SELL
$4.83 - $7.56 $309,366 - $484,225
-64,051 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$6.2 - $8.34 $832,306 - $1.12 Million
-134,243 Reduced 67.7%
64,051 $430,000
Q2 2021

Aug 16, 2021

BUY
$6.04 - $8.37 $1.2 Million - $1.66 Million
198,294 New
198,294 $1.57 Million

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $273M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.